Healthcare ❯ Pharmaceuticals ❯ Drug Approval

Clinical Trials

MAVIRET Phase 3 Trials TN-10 Study Dupixent ALS Treatment Chronic Myeloid Leukemia Biogen FDA Regulations SELECT Trial Patient Care Bipolar Disorder Regulatory Framework Zuranolone HIV Prevention FDA Elinzanetant Efficacy

FDA Approves Vanda’s Bysanti for Bipolar I Mania and Schizophrenia

Vanda secured clearance using bridged iloperidone evidence to speed the review.

EU Medicines Panel Backs Teizeild to Delay Type 1 Diabetes Onset

Lancet Series Calls for Health-System Overhaul to Deliver New Alzheimer’s Blood Tests and Antibody Drugs

EMA Committee Recommends EU Approval for First Oral Postpartum Depression Treatment